Featured Research

from universities, journals, and other organizations

Adult survivors of childhood cancer at risk of early aging

Date:
November 18, 2013
Source:
St. Jude Children's Research Hospital
Summary:
Young adults who survived childhood cancer are more likely than their peers to be frail. Research suggests that the condition is more common among female survivors than women decades older.

Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the current edition of the Journal of Clinical Oncology.

Researchers also found that frail health was associated with a greater risk for adult childhood cancer survivors of death and chronic disease. Being frail was defined by the presence of at least three of the following -- weakness, self-reported exhaustion, physical inactivity, low muscle mass and slow walking speed. In the general population, it is most commonly associated with advancing age.

In this study of 1,922 childhood cancer survivors, 13.1 percent of women and 2.7 percent of men qualified as frail despite having an average age of less than 34 years old. In a comparison group of 341 young adults with an average age of 29 years old and no history of childhood cancer, none qualified as frail. Nationally, an estimated 9.6 percent of women age 65 and older and 5.2 percent of men in the same age group meet the definition. The unexpectedly high prevalence of frailty among childhood cancer survivors suggests accelerated aging, researchers said.

After adjusting for existing chronic health problems, researchers calculated that frail childhood cancer survivors were 2.6 times more likely to die than their non-frail counterparts. The risk was highest for frail male survivors, who were at a six-fold increased risk of death compared to male survivors who were not frail. Frail survivors were also more than twice as likely as survivors who were not frail to develop additional chronic health problems.

"There are steps survivors can take to reduce their risk and improve their fitness," said the study's first and corresponding author Kirsten Ness, Ph.D., an associate member of the St. Jude Department of Epidemiology and Cancer Control. Exercise can reverse frailty in the elderly, and Ness said this study reinforces the need for survivors to work with their health care providers to become more fit.

Ness said quantifying the extent of frailty among childhood cancer survivors will help the medical community recognize and respond to the unique health needs of this growing population, which includes more than 400,000 U.S. residents. St. Jude is working on strategies to prevent or address the condition in this at-risk group.

These results are just the latest findings from the St. Jude Lifetime Cohort Study (St. Jude LIFE). St. Jude LIFE brings the hospital's pediatric cancer survivors back to campus for two to three days of medical testing and assessments. The goal is to better understand and address the challenges facing childhood cancer survivors as they age.

The survivors in this study were treated at St. Jude between 1962 and 2003. At least 10 years had passed since their cancer diagnosis when they joined St. Jude LIFE.

This study found frailty was more common among male survivors who smoked, were underweight and whose pediatric cancer treatment included abdominal or pelvic irradiation. In contrast, lifestyle was not associated with frailty risk in female survivors.

Cranial irradiation was associated with a greater likelihood of frailty in men and women. St. Jude is a pioneer in reducing radiation in treatment of childhood cancer, particularly the most common childhood cancer, acute lymphoblastic leukemia (ALL). Rates of frailty were highest among survivors of central nervous system tumors and other solid tumors, including soft-tissue sarcomas.

Work is underway to better understand frailty in childhood cancer survivors, including how it mirrors or differs from age-related frailty.

For example, in the elderly, muscle weakness appears to precede loss of muscle mass. That differs from childhood cancer survivors, who commonly have less lean muscle mass than Americans of the same age, sex and race. Lean muscle is the skeletal muscle that is the basis of strength and function. Patients experience cancer-related muscle wasting during treatment when nutrition and exercise are also a struggle. The late effects of treatment, including hormonal abnormalities and physical disability, may make it difficult for some survivors to fully recover.


Story Source:

The above story is based on materials provided by St. Jude Children's Research Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. I.-C. Huang, T. M. Brinkman, K. Kenzik, J. G. Gurney, K. K. Ness, J. Lanctot, E. Shenkman, L. L. Robison, M. M. Hudson, K. R. Krull. Association Between the Prevalence of Symptoms and Health-Related Quality of Life in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study. Journal of Clinical Oncology, 2013; 31 (33): 4242 DOI: 10.1200/JCO.2012.47.8867

Cite This Page:

St. Jude Children's Research Hospital. "Adult survivors of childhood cancer at risk of early aging." ScienceDaily. ScienceDaily, 18 November 2013. <www.sciencedaily.com/releases/2013/11/131118193022.htm>.
St. Jude Children's Research Hospital. (2013, November 18). Adult survivors of childhood cancer at risk of early aging. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2013/11/131118193022.htm
St. Jude Children's Research Hospital. "Adult survivors of childhood cancer at risk of early aging." ScienceDaily. www.sciencedaily.com/releases/2013/11/131118193022.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins